Table 2.
Parameter
|
Total | Mild
|
Moderate
|
Severe
|
P-value | |||
---|---|---|---|---|---|---|---|---|
Canadian neurological scale |
|
8.5 to 10
|
2.5 to 8
|
0 to 2
|
||||
Number of patients | Number of patients | Number of patients | Number of patients | |||||
Glasgow coma scale | 102 | 69 | 14.9±0.3 | 20 | 14±2 | 13 | 11±4 | 0.001 |
Nonlacunar infarct volume (mL) | 48 | 23 | 20±23 | 17 | 51±69 | 8 | 69±62 | 0.05 |
Lacunar infarct volume (mL) | 54 | 46 | 3±3 | 3 | 2±2 | 5 | 8±8 | 0.009 |
hs-CRP (mg/dL) | 102 | 69 | 5±6 | 20 | 8±6 | 13 | 12±7 | 0.001 |
Lp-PLA2 (nmol/min/mL) | 102 | 69 | 96±88 | 20 | 143±78 | 13 | 163±60 | 0.008 |
Notes: Data reported as number or mean ± standard deviation. Statistical significance was defined as P≤0.05.
Abbreviations: hs-CRP, high-sensitivity C-reactive protein; Lp-PLA2, lipoprotein-related phospholipase A2.